SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RAVANI, Annalisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.235
AS - Asia 1.077
EU - Europa 526
SA - Sud America 220
Continente sconosciuto - Info sul continente non disponibili 55
AF - Africa 24
OC - Oceania 3
Totale 4.140
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.181
SG - Singapore 419
CN - Cina 256
BR - Brasile 177
IT - Italia 136
VN - Vietnam 117
DE - Germania 89
HK - Hong Kong 77
TR - Turchia 65
UA - Ucraina 49
GB - Regno Unito 44
FI - Finlandia 40
FR - Francia 35
PL - Polonia 34
BD - Bangladesh 32
CA - Canada 30
SE - Svezia 30
RU - Federazione Russa 23
IN - India 22
JP - Giappone 21
ID - Indonesia 17
MX - Messico 17
AR - Argentina 13
ZA - Sudafrica 11
NL - Olanda 10
CO - Colombia 9
ES - Italia 8
IQ - Iraq 8
EC - Ecuador 7
LT - Lituania 7
SA - Arabia Saudita 7
UZ - Uzbekistan 6
VE - Venezuela 6
AT - Austria 5
AE - Emirati Arabi Uniti 4
MY - Malesia 4
PK - Pakistan 4
BG - Bulgaria 3
KE - Kenya 3
KR - Corea 3
MA - Marocco 3
NG - Nigeria 3
NP - Nepal 3
PY - Paraguay 3
RO - Romania 3
AU - Australia 2
CG - Congo 2
CL - Cile 2
HU - Ungheria 2
KZ - Kazakistan 2
MN - Mongolia 2
PH - Filippine 2
PT - Portogallo 2
UY - Uruguay 2
AL - Albania 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
HN - Honduras 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
TN - Tunisia 1
TW - Taiwan 1
VG - Isole Vergini Britanniche 1
Totale 4.085
Salva come PNG Salva come JPEG
Città #
Ashburn 308
Singapore 265
Fairfield 195
Woodbridge 169
San Jose 111
Houston 107
Ann Arbor 106
Chandler 97
Beijing 94
Santa Clara 92
Seattle 85
Wilmington 77
Hong Kong 74
Jacksonville 69
Cambridge 67
Los Angeles 54
Izmir 40
Ho Chi Minh City 38
Munich 34
Ferrara 33
New York 32
Warsaw 31
Dallas 29
The Dalles 29
Council Bluffs 25
Hanoi 23
Shanghai 23
Nanjing 22
Turku 22
Tokyo 19
Princeton 17
Toronto 17
São Paulo 16
Boardman 15
Frankfurt am Main 15
Milan 15
Falls Church 13
Jakarta 13
Lauterbourg 12
Buffalo 11
Columbus 11
Chicago 9
Atlanta 8
Brooklyn 8
Des Moines 8
Jiaxing 8
Johannesburg 8
Manchester 8
Nanchang 8
Rio de Janeiro 8
Auburn Hills 7
Denver 7
London 7
Mexico City 7
San Francisco 7
Jeddah 6
Montreal 6
Norwalk 6
Orem 6
Salvador 6
San Diego 6
Stockholm 6
Tashkent 6
Tianjin 6
Ankara 5
Charlottesville 5
Haiphong 5
Mountain View 5
Phoenix 5
Biên Hòa 4
Bologna 4
Cagliari 4
Changsha 4
Chennai 4
Medellín 4
Moscow 4
Querétaro 4
Redwood City 4
Rome 4
Baghdad 3
Can Tho 3
Dearborn 3
Florence 3
Goiânia 3
Guangzhou 3
Guayaquil 3
Hebei 3
Helsinki 3
Juneau 3
Kuala Lumpur 3
Lagos 3
Motta di Livenza 3
Mumbai 3
Newark 3
Orange 3
Portland 3
Quito 3
Quảng Ngãi 3
Ribeirão das Neves 3
Rio Grande 3
Totale 2.815
Salva come PNG Salva come JPEG
Nome #
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 314
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 304
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 281
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 268
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 264
Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: Relevance for Parkinson’s disease and Schizophrenia 259
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 257
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 244
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 226
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 225
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 216
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 214
Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers 208
RAW 264.7 co-cultured with ultra-high molecular weight polyethylene particles spontaneously differentiate into osteoclasts: an in vitro model of periprosthetic osteolysis 192
Pharmacological characterization of adenosine receptors in chronic inflammatory rheumatic diseases 181
Effects of pulsed electromagnetic fields and platelet rich plasma in preventing osteoclastogenesis in an in vitro model of osteolysis 167
Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation 146
null 91
null 83
Totale 4.140
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.575
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022166 0 13 7 12 7 18 16 7 16 20 16 34
2022/2023223 20 18 13 24 33 26 17 19 33 0 11 9
2023/2024140 21 8 4 3 7 15 8 40 2 4 5 23
2024/2025675 14 15 42 39 54 86 50 42 112 34 100 87
2025/20261.568 161 66 131 191 271 103 193 72 130 136 66 48
2026/202769 57 12 0 0 0 0 0 0 0 0 0 0
Totale 4.140